Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy develop complications with their eyesight, highlighting that we ...

Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates for its ...

Researchers are studying whether popular weight-loss drugs could reduce cravings not only for food, but for alcohol, heroin and other addictive drugs. Some patients taking the drugs for weight loss ...

In the realm of weight loss supplements, SVELTE Keto + ACV Gummies have emerged as a frontrunner, promising a revolutionary approach to fat burning and energy enhancement. Combining the principles of ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Too many young people are prescribed pills for mental illness. Are we repeating history with GLP-1s?

Whoopi Goldberg issues warning about fake social media ad of her endorsing weight loss treatment - ‘The View’ host previously ...

EGOT winner Whoopi Goldberg railed against an ad that's circulating on social media with a manipulated version of her ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...